Sonepcizumab
Product Specifications
CAS Number
1031360-18-5
Target
LPL Receptor
Related Pathways
GPCR/G Protein
Purity
0.989
Bioactivity
Sonepcizumab (LT 1009) is a fully humanized monoclonal antibody against S1P, with anti-cancer activity, useful for studying metastatic renal cell carcinoma (mRCC) and preventing eye scarring after glaucoma filtration surgery.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
SFPA240Hu61-01 10 µg
Eukaryotic Procollagen I C-Terminal Propeptide (PICP)
Sign In for Pricing
View Details SFPA240Hu61-02 50 µg
Eukaryotic Procollagen I C-Terminal Propeptide (PICP)
Sign In for Pricing
View Details SFPA240Hu61-03 200 µg
Eukaryotic Procollagen I C-Terminal Propeptide (PICP)
Sign In for Pricing
View Details SFPA240Hu61-04 1 mg
Eukaryotic Procollagen I C-Terminal Propeptide (PICP)
Sign In for Pricing
View Details SFPA240Hu61-05 5 mg
Eukaryotic Procollagen I C-Terminal Propeptide (PICP)
Sign In for Pricing
View Details 